M&A Deal Summary

PharmaLex Acquires Lindeq AS

On March 23, 2016, PharmaLex acquired life science company Lindeq AS

Acquisition Highlights
  • This is PharmaLex’s 1st transaction in the Life Science sector.
  • This is PharmaLex’s 1st transaction in Norway.

M&A Deal Summary

Date 2016-03-23
Target Lindeq AS
Sector Life Science
Buyer(s) PharmaLex
Deal Type Add-on Acquisition

Target

Lindeq AS

Oslo, Norway
Lindeq AS is a medical consultancy specialized in drug safety and pharmacovigilance, cosmetovigilance, quality management, and medical device vigilance. Lindeq AS services offered stretch cover the entire product lifecycle - pre and post product launch.

Search 215,074 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

PharmaLex

Frankfurt, Germany

Category Company
Sector Life Science
DESCRIPTION

PharmaLex is a provider of solutions for drug development, regulatory affairs, and pharmacovigilance. The company features a multidisciplinary team from more than 40 nationalities with knowledge that spans the whole spectrum of life sciences, including biology, biochemistry, pharmacology, engineering, food chemistry, medicine, nutritional science, pharmacy science, toxicology, and veterinary medicine. PharmaLex is based in Frankfurt, Germany.


DEAL STATS #
Overall 2 of 13
Sector: Life Science M&A 1 of 4
Type: Add-on Acquisition M&A Deals 1 of 10
Country: Norway M&A 1 of 1
Year: 2016 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-10-14 YES Pharmaceutical Development Services

Friedrichsdorf, Germany

YES Pharmaceutical Development Services GmbH is a highly specialized service provider in the fields of regulatory affairs, product development and drug safety for pharmaceuticals, medical devices, and cosmetics.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-17 Arlenda S.A.

Belgium

Arlenda S.A. specializes in strategic consulting for clinical and non-clinical statistics. In clinical statistics, Arlenda is focused on the optimization of clinical trial designs by simulation with a specialization in adaptive designs.

Buy -